Navigation Links
IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
Date:3/20/2008

IRVINE, Calif., March 20 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (the Company) (Nasdaq: IDMI) announced today that it has initiated enrollment in a clinical protocol finalized with the U.S. Food and Drug Administration (FDA), which provides mifamurtide (L-MTP-PE) to eligible, high-risk osteosarcoma patients through a compassionate access study.

"This formalized study is in response to the increasing number of requests for compassionate access to L-MTP-PE," said Timothy P. Walbert, president and chief executive officer, IDM Pharma. "As we continue to navigate the U.S. and European regulatory processes, we hope this study provides a temporary solution and much needed treatment option for patients with this devastating orphan disease."

Data from 13 patients treated through compassionate access were presented at the 39th Congress of International Society of Pediatric Oncology (SIOP) last year and showed that L-MTP-PE in combination with other therapies is safe, well-tolerated and exhibited signs of disease control. Updated data on the increasing number of patients treated through compassionate access will be presented at the upcoming 21st Annual Meeting of The American Society of Pediatric Hematology/Oncology (ASPHO).

"This compassionate access study is designed to meet an unmet treatment need by providing L-MTP-PE access to high-risk osteosarcoma patients for whom current therapy is not effective or tolerated," said Peter Anderson, M.D., Ph.D., principal investigator and professor of pediatrics, The University of Texas M. D. Anderson Cancer Center in Houston. "Our experience in treating patients with L-MTP-PE in Phase 1, Phase 2, and Phase 3 studies and through compassionate access has been positive to date with good
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
2. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
3. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
4. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
5. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
6. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
7. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
8. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
9. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition of ... Size, Share, Growth, Trends And Forecast, 2013 - 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 ) Dental consumables ... to treat dental impairments, for tooth restoration and in ...
(Date:1/15/2014)... IRVING, Texas , Jan. 15, 2014  Novation, the ... company, awarded several new IT value-added reseller (VAR) national ... with IT goods and services at lower costs. These ... value-added services such as initiative assistance and ongoing IT ...
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
(Date:4/23/2014)... Parents and physicians concerned about an increase in ... can breathe a sigh of relief. According to a ... years worth of data from states with and without ... to increased use among adolescents. The study is published ... of Adolescent Health . , "Any time a ...
(Date:4/23/2014)... that proliferation of endogenous neural precursor cells cannot ... axons. From the perspective of neural plasticity, Dr. ... in China observed the effects of functional electrical ... and expression of basic fibroblast growth factor and ... the infarct side. The researchers found that functional ...
(Date:4/22/2014)... FDA-approved device has been shown to reduce seizures in ... percent. When coupled with an innovative electrode placement planning ... the complete elimination of seizures in nearly half of ... trials. , That,s good news for a large portion ... with epilepsy whose seizures can,t be controlled with medications ...
(Date:4/22/2014)... 15 percent of all lung cancers are small ... often develop resistance to chemotherapy. However, researchers at ... new insights into the mechanisms leading to this ... , Chemotherapies work primarily by mediating B-cell lymphoma ... regulating cell death. Depending on their function, this ...
(Date:4/22/2014)... mice and rabbits, Johns Hopkins scientists have found a ... successfully preventing the development of atherosclerosis, the main cause ... of death among humans. The condition develops when fat ... stiff, narrowed and hardened, greatly reducing their ability to ... brain. , In a series of experiments, described April ...
Breaking Medicine News(10 mins):Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4
... Community Unites Behind Extraordinary Global Effort, ... SAN FRANCISCO, July 23 The Medpedia ... largest collaborative online,encyclopedia of medicine called Medpedia. ... health professionals are now,volunteering to collaboratively build ...
... treatment and prognosis may be affected, study says , , ... or pancreatic cancer may have more lymph nodes examined ... designated comprehensive cancer centers or at hospitals that do ... study. , If too few lymph nodes are examined ...
... international scientific and professional organization of more than ... technology and science of molecular imaging and nuclear ... nuclear medicine and molecular imaging research. The awards, ... announced at SNM,s 55th Annual Meeting, held in ...
... program saves time, reduces costs and increases safety; $1000 incentive may ... ... Chapel Hill, NC (PRWEB) July 22, 2008 -- Imagine a health ... prescription into a PDA or computer, and getting immediate feedback about ...
... head and neck cancer, accurately determining how advanced the cancer ... until now. New Saint Louis University research has found ... tool to detect secondary cancers, which occur in 5 to ... study findings, which will be presented on Tuesday, July 22 ...
... body, they could lead to nonsurgical treatments , , TUESDAY, July ... valuable in efforts to develop nonsurgical treatments for spinal cord ... and Sweden. , They say it may be possible to ... to repair damaged nerve cells. , An adult,s spinal cord ...
Cached Medicine News:Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 2Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 3Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 4Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 5Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 6Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 7Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 8Health News:More Cancer Lymph Nodes Analyzed at Specialty Centers 2Health News:Seeding the future: SNM grants grow molecular imaging and nuclear medicine research 2Health News:Seeding the future: SNM grants grow molecular imaging and nuclear medicine research 3Health News:BCBSNC Makes Electronic Prescribing Available Statewide 2Health News:BCBSNC Makes Electronic Prescribing Available Statewide 3Health News:BCBSNC Makes Electronic Prescribing Available Statewide 4Health News:Has cancer spread? Research identifies best way to find answers so treatment can begin 2Health News:Spinal Cord Stem Cells May Act as Nerve Repair System 2
Optimal solution for normal acetabulum....
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
... The integration of Trabecular Metal ... proven implant design results in a ... not only meets surgeon demands for ... provides a wide variety of shell ...
Medicine Products: